Gastroesophageal reflux disease

Journal of the American Geriatrics Society

Volumn 46, Issue 12, 1998, Pages 1558-1565

  Katz, Philip O ^a,b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Pepper Pavilion   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CISAPRIDE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METOCLOPRAMIDE; NIZATIDINE; OMEPRAZOLE; PROKINETIC AGENT; PROTON PUMP INHIBITOR; RANITIDINE;

ANTIREFLUX OPERATION; BARRETT ESOPHAGUS; ESOPHAGITIS; ESOPHAGUS STRICTURE; GASTROESOPHAGEAL REFLUX; HUMAN; LARYNGITIS; LUNG INJURY; REVIEW;

EID: 0031770898     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1998.tb01543.x     Document Type: Review

References (63)

1. A Gallup survey on heartburn across America. Princeton, NJ: The Gallup Organization, 1968.
2. Locke GR, Talley NJ, Fett SL et al. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmstead County, Minnesota. Gastroenterology 1997;112:5-12.
3. Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: Incidence and precipitating factors. Dig Dis Sci 1976;21:953-956.
4. DeVault KR, Castell DO. Current diagnosis and treatment of gastroesophageal reflux disease. Mayo Clin Proc 1994;69:867-876.
5. Winters C, Spurling TJ, Chobanian SJ et al. Barrett's esophagus: A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987;92:118-123.
6. Collen MJ, Abdulian JD, Chen YK. Gastroesophageal reflux in the elderly: More severe disease that requires aggressive therapy. Am J Gastroenterol 1995;90:1053-1057.
7. Brunnen PL, Karmody AM, Needham CD. Severe peptic oesophagitis. Gut 10:831-837.
8. Raiha I, et al. Symptoms of gastroesophageal reflux disease in elderly people. Age Ageing 1992;20:365-370.
9. El-Serag, HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology 1997;113:755-760.
10. Brzana RJ, Koch K. Gastroesopohageal reflux disease presenting with intractable nausea. Ann Intern Med 1997;9:704-707.
11. Harding SM, Guzzo MR, Richter JE. Prevalence of GERD in asthmatics without reflux symptoms. Gastroenterology 1997;4:A141.
12. Sontag SJ, O'Connell S, Khandelwal S et al. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 1990;99:613-618.
13. Irwin RS, Corrao WM, Pratter MR. Chronic persistent cough in the adult: The spectrum and frequency of causes and successful outcome of specific therapy. Am Rev Respir Dis 1981;123:413-422.
14. Weiner GJ, Kaufman JA, Wu WC et al. Chronic hoarseness secondary to gastroesophageal reflux disease. Am J Gastroenterol 1989;84:1503-508.
15. Hewson EG, Sinclair JW, Dalton CB et al. 24 hour esophageal pH monitoring: The most useful test for evaluating non-cardiac chest pain. Am J Med 1991;90:576-583.
16. Cherian P, Smith LF, Bardham KD et al. Esophageal tests in the evaluation of non-cardiac chest pain. Dis Esophagus 1995;8:129-33.
17. Larrain A, Carrasco E, Galleguillos F et al. Medical and surgical treatment of non-allergic asthma associated with gastroesophageal reflux. Chest 1991; 99:1330-1336.
18. Sontag SJ, Schnell TG, Miller TQ et al. Prevalence of oesophagitis in asthmatics. Gut 1992;33:872-876.
19. Waring JP, Hunter JG, Wo JM et al. GERD symptoms, medication use and endoscopic findings in elderly patients with peptic strictures: Am J Gastroenterol 1997;92:Abstract 91.
20. Dent J, Dodds WJ Friedman RH et al. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest 1980;65:256-267.
21. Hollis JB, Castell DO. Esophageal function in elderly men: A new look at presbyesophagus. Ann Intern Med 1974;80:371-377.
22. Kahrilas PJ, Dodds WJ, Hogan WJ et al. Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology 1986;91:897-804.
23. Barrett J, Peghini P, Katz P et al. Ineffective esophageal motility (IEM): The most common manometric abnormality in GERD. Gastroenterology 1997; 112:4:Abstract 66.
24. Stilson W. Hiatal hernia and gastroesophageal reflux. Radiology 1969;93: 1323-1337.
25. Leite LP, Johnston BT, Barrett J et al. Ineffective esophageal motility (IEM). The primary finding in patients with nonspecific esophageal motility disorder. Dig Dis Sci 1997;42:1859-1865.
26. Fouad YM, Khoury R, Hattlebakk JG et al. Ineffective esophageal motility (IEM) is more prevalent in reflux patients with respiratory symptoms. Gastroenterology 1968;114:Abstract.
27. Sonnenberg A. Salivary secretion in reflux esophagitis. Gastroenterology 1982;83:889-897.
28. Lasch H, Castell DO, Castell JA. Evidence for diminished visceral pain with aging: Studies using graded intraesophageal balloon distension. Am J Physiol 1997;272:G1-3.
29. Collen MJ, Abdulian JD, Chen YK. Age does not affect basal gastric acid secretion in normal subjects and acid-peptic disease. Am J Gastroenterol 1994;89:712-716.
30. Goldschmiedt M, Barnett CC, Schwarz BE et al. Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women. Gastroenterology 1991;101:977-990.
31. Ott DJ, Wu WC, Gelfand DW. Reflux esophagitis revisited: Prospective analysis of radiologic accuracy. Gastrointest Radiol 1981;6:1-7.
32. Richter JE, Castell DO. Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy. Ann Intern Med 1982;97:93-103.
33. Lieberman DA, Oehlke M, Helfand M, and the GORGE Consortium. Risk factors for Barrett's esophagus in community-based practice. Am J Gastroenterol 92:8 1997:1293-1297.
34. DeVault KR, Castell DO. Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Arch Intern Med 1995;155:2165-2173.
35. Hetzel D, Dent J, Reed W et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903-912.
36. Ismail-Beigi F, Horton PF, Pope CE. Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970;58:163-174.
37. Spechler SJ. Complications of Gastroesophageal Reflux Disease: The Esophagus, Castell DO, ed. Little Brown and Co., 1995, pp 533-546.
38. Schnatz PF, Castell JA, Castell DO. Pulmonary symptoms associated with gastroesophageal reflux: Use of ambulatory pH monitoring to diagnose and to direct therapy. Am J Gastroenterol 1996;91:1715-1718.
39. Harding SM, Richter JE, Guzzo MR et al. Asthma and gastroesophageal reflux: Acid suppression therapy improves asthma outcome. Am J Med 1996;100:395-405.
40. Palmer ED. The hiatus hernia-esophagitis-esophageal stricture complex. Twenty-year prospective study. Am J Med 1968;44:566-572.
41. Sloan S, Kahrilas PJ. Impairment of esophageal emptying with hiatal hernia. Gastroenterology 1991;100:596-605.
42. Sloan S, Rademaker AW, Kahrilas PJ. Determinants of gastroesophageal junction incompetence: Hiatal hernia, lower esophageal sphincter, or both? Ann Intern Med 1992;117:977-982.
43. Kikendall JW. Pill-induced esophageal injury: Case reports and review of the medical literature. Dig Dis Sci 1983;28:174-185.
44. Sontag S, Robinson M, McCallum RW et al. Ranitidine therapy for gastroesophageal reflux disease. Results of a large double blind trial. Arch Intern Med 1987;147:1485-1491.
45. Euler AR, Murdock RH, Wilson TH et al. Ranitidine is effective therapy for erosive esophagitis. Am J Gastroenterol 1993;88:520-524.
46. Blum AL, Adami B, Bouzo M et al. Effect of cisapride on relapse of esophagitis. Dig Dis Sci 1993;38:551-560.
47. Castell D, Sigmund C, Patterson D et al. Cisapride 20 mg bid provides effective daytime and nighttime relief in patients with symptoms of chronic gastroesophageal reflux disease. Gastroenterology 1997;112:Abstract.
48. Lieberman DA, Keefe EB. Treatment of severe reflux esophagitis with cimetidine and metoclopramide. Ann Intern Med 1986;333:1106-1110.
49. Sandmark S, Carlsson R, Falso O, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Scand J Gastroenterol 1988;23:625-632.
50. Hetzel D, Dent J, Reed W et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903-912.
51. Castell DO, Richter JE, Robinson M et al. Efficacy and safety of lansoprazole in the treatment of erosive esophagitis. Am J Gastroenterol 1996;91: 1749-1758.
52. Vignieri S, Termini R, Leandro G et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995;333:1106-1110.
53. Klinkenberg-Knol E, Festen H, Jansen J et al. Long term treatment with omeprazole for refractory esophagitis. Ann Intern Med 1994;121:161-167.
54. Zimmermann A, Walters JK, Katona B, Souney P. Alternative methods of proton pump inhibitor administration. Consult Pharm 1997;9:990-998.
55. Kuo B, Castell DO. Optimal dosing of omeprazole 40 mg daily: Effects on gastric and esophageal pH and serum gastnn in healthy controls. Am J Gastroenterol 1996;91:1532-1538.
56. Kuipers EJ, Lundell L, Klinkenberg-Knol EC et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334:1018-1022.
57. 56, Proton pump inhibitor relabeling for cancer risk not warranted. FDA Reports, Nov. 11, 1996.
58. Katzka DA, Paoletti V, Leite L, Castell DO. Prolonged ambulatory pH monitoring in patients with persistent GERD symptoms. Testing while on therapy identifies need for more aggressive antireflux therapy. Am J Gastroenterol 1996;91:2110-2113.
59. Marks RD, Richter JE, Rizzo J et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis. Gastroenterology 1994;106:907-915.
60. Falk GW. Barrett's esophagus. Gastrointest Endosc Clin North Am 1994;4: 773-89.
61. Sampliner RE. Effect of up to 3 years of high-dose lansoprazole on Barretts esophagus. Am J Gastroenterol 89:1844-1848.
62. Sataloff DM, Pursani K, Hoyo S et al. An objective assessment of laparoscopic antireflux surgery. Am J Surg 1997;174:63-67.
63. Hinder RA, Filipi CJ, Wetscher G et al. Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg 1994; 220:472-483.